Open AccessP582: FIRST RESULTS OF A PHASE II STUDY (STIMULUS‐AML1) INVESTIGATING SABATOLIMAB + AZACITIDINE + VENETOCLAX IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
Author(s) -
Zeidan A. M.,
Westermann J.,
Kovacsovics T.,
Assouline S.,
Schuh A. C.,
Kim H.J.,
Rodriguez Macias G.,
Sanford D.,
Luskin M. R.,
Stein E. M.,
Malek K.,
Lyu J.,
Stegert M.,
Esteve J.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845216.33320.a2
Subject(s) - medicine , azacitidine , venetoclax , myeloid leukemia , myeloid , ven , oncology , tolerability , leukemia , gastroenterology , adverse effect , chronic lymphocytic leukemia , biochemistry , gene expression , computer security , computer science , dna methylation , gene , chemistry